|
Docetaxel EP impurity C
|
多西他賽EP雜質(zhì)C
|
153381-68-1
|
|
Docetaxel Impurity 14
|
多西他賽雜質(zhì)14
|
146924-94-9
|
|
Docetaxel Impurity 13
|
多西他賽雜質(zhì)13
|
126150-57-0
|
|
Docetaxel Impurity 11
|
多西他賽雜質(zhì)11
|
133524-69-3
|
|
Docetaxel Impurity 9
|
多西他賽雜質(zhì)9
|
161759-90-6
|
|
Levofloxacin Diformyl Impurity
|
左氧氟沙星二甲?；s質(zhì)
|
151377-74-1
|
|
Docetaxel Impurity 19
|
多西他賽雜質(zhì)19
|
92950-45-3
|
|
Docetaxel Impurity 20
|
多西他賽雜質(zhì)20
|
151636-94-1
|
|
Docetaxel Impurity 8
|
多西他賽雜質(zhì)8
|
|
|
Docetaxel Impurity 6 Sodium Salt
|
多西紫杉醇雜質(zhì) 6 鈉鹽
|
|
|
Docetaxel Impurity 4 Sodium Salt
|
多西紫杉醇雜質(zhì)4鈉鹽
|
|
|
Docetaxel Impurity 3
|
多西他賽雜質(zhì)3
|
172018-16-5
|
|
Docetaxel Impurity 2
|
多西他賽雜質(zhì)2
|
158810-72-1
|
|
Docetaxel Impurity 5
|
多西他賽雜質(zhì)5
|
1021489-55-3
|
|
Docetaxel Impurity 24
|
多西他賽雜質(zhì)24
|
1217248-58-2
|
|
Ritonavir Impurity 4
|
利托那韋雜質(zhì)4
|
1010809-54-7
|
|
O-Acetyl Ritonavir
|
O-乙酰利托那韋
|
|
|
Ritonavir EP Impurity P
|
利托那韋EP雜質(zhì)P
|
|
|
Dehydroritonavir
|
脫氫利托那韋
|
|
|
Ritonavir EP Impurity C
|
利托那韋EP雜質(zhì)C
|
1010808-43-1
|
|
Ritonavir EP Impurity F
|
利托那韋EP雜質(zhì)F
|
1010809-61-6
|
|
Ritonavir EP Impurity R
|
利托那韋EP雜質(zhì)R
|
|
|
Ritonavir EP Impurity Q
|
利托那韋EP雜質(zhì)Q
|
1414933-82-6
|
|
Ritonavir EP Impurity J
|
利托那韋EP雜質(zhì)J
|
162849-95-8
|
|
Ritonavir Impurity 17
|
利托那韋雜質(zhì)17
|
38585-74-9
|
|
Ritonavir EP Impurity O
|
利托那韋EP雜質(zhì)O
|
1414933-81-5
|
|
Ritonavir EP Impurity L
|
利托那韋EP雜質(zhì)L
|
256328-82-2
|
|
Ritonavir Impurity E
|
利托那韋雜質(zhì)E
|
176655-56-4
|
|
Ritonavir EP Impurity T
|
利托那韋EP雜質(zhì)T
|
869368-48-9
|
|
Ritonavir Impurity G
|
利托那韋雜質(zhì)G
|
|
|
Sorafenib related compound 10
|
索拉非尼相關(guān)化合物10
|
1012058-78-4
|
|
Sorafenib Impurity 18
|
索拉非尼雜質(zhì)18
|
370-50-3
|
|
Sorafenib Impurity 6
|
索拉非尼雜質(zhì)6
|
2204442-52-2
|
|
Sorafenib related compound 9
|
索拉非尼相關(guān)化合物9
|
343247-69-8
|
|
Sorafenib related compound 8
|
索拉非尼相關(guān)化合物8
|
1129683-88-0
|
|
Sorafenib
|
索拉非尼
|
284461-73-0
|
|
Sorafenib related compound 13
|
索拉非尼相關(guān)化合物13
|
845306-04-9
|
|
Sorafenib Related Compound 22
|
索拉非尼相關(guān)化合物22
|
284462-89-1
|
|
Sorafenib related compound 19
|
索拉非尼相關(guān)化合物19
|
1012058-77-3
|
|
Sorafenib related compound 16
|
索拉非尼相關(guān)化合物16
|
1256817-30-7
|
|
Docetaxel EP Impurity G
|
多西他賽EP雜質(zhì)G
|
125354-16-7
|
|
Docetaxel Impurity 30
|
多西他賽雜質(zhì)30
|
161183-22-8
|
|
2-Debenzoyl-2-Pentenoyl Docetaxel
|
2-去苯甲酰-2-戊烯酰多西紫杉醇
|
1412898-66-8
|
|
Docetaxel Impurity 17
|
多西他賽雜質(zhì)17
|
194235-02-4
|
|
Docetaxel Impurity 16
|
多西他賽雜質(zhì)16
|
194235-04-6
|
|
Docetaxel Impurity 15
|
多西他賽雜質(zhì)15
|
146924-91-6
|
|
Docetaxel EP impurity D
|
多西他賽EP雜質(zhì)D
|
162784-72-7
|
|
Docetaxel Impurity 45
|
多西他賽雜質(zhì)45
|
1095547-98-0
|
|
Docetaxel Impurity 47
|
多西他賽雜質(zhì)47
|
1385028-85-2
|
|
Docetaxel Impurity 49
|
多西他賽雜質(zhì)49
|
147058-27-3
|
|
Docetaxel EP impurity A
|
多西他賽EP雜質(zhì)A
|
1887057-05-7
|
|
Tinidazole Impurity 1
|
替硝唑雜質(zhì)1
|
13230-19-8
|
|
Tinidazole Impurity 10 HCl
|
替硝唑雜質(zhì)10鹽酸鹽
|
595596-97-7
|
|
Tinidazole Impurity 11
|
替硝唑雜質(zhì)11
|
140165-54-4
|
|
Tinidazole Impurity 14 HCl
|
替硝唑雜質(zhì)14鹽酸鹽
|
215034-20-1
|
|
Tinidazole EP Impurity A
|
替硝唑EP雜質(zhì)A
|
696-23-1
|
|
Tinidazole Impurity 6
|
替硝唑雜質(zhì)6
|
140165-55-5
|
|
Tinidazole Impurity 3
|
替硝唑雜質(zhì)3
|
28795-33-7
|
|
Docetaxel EP impurity B
|
多西他賽EP雜質(zhì)B
|
167074-97-7
|
|
Ritonavir EP Impurity S
|
利托那韋EP雜質(zhì)S
|
|
|
Tinidazole EP Impurity B
|
替硝唑EP雜質(zhì)B
|
25459-12-5
|
|
Tinidazole Impurity 8
|
替硝唑雜質(zhì)8
|
1889-59-4
|
|
Ritonavir EP Impurity H
|
利托那韋EP雜質(zhì)H
|
1010809-43-4
|
|
Ritonavir EP Impurity B HCl
|
利托那韋EP雜質(zhì)B鹽酸鹽
|
|
|
Ritonavir Impurity 8
|
利托那韋雜質(zhì)8
|
220887-40-1
|
|
Ritonavir Impurity 7
|
利托那韋雜質(zhì)7
|
220887-39-8
|
|
Ritonavir Impurity 6
|
利托那韋雜質(zhì)6
|
220887-42-3
|
|
Ritonavir Impurity 5
|
利托那韋雜質(zhì)5
|
183246-46-0
|
|
Ritonavir EP Impurity I
|
利托那韋EP雜質(zhì)I
|
165315-26-4
|
|
Ritonavir EP Impurity U
|
利托那韋EP雜質(zhì)U
|
|
|
Sorafenib EP Impurity E
|
索拉非尼EP雜質(zhì)E
|
284670-98-0
|
|
Sorafenib Impurity 12
|
索拉非尼雜質(zhì)12
|
284461-74-1
|
|
(S)-Ofloxacin EP Impurity B (Decarboxyl Levofloxacin)
|
（S）-氧氟沙星EP雜質(zhì)B
|
178964-53-9
|
|
Levofloxacin EP Impurity F (Levofloxacin Related Compound B)
|
左氧氟沙星EP雜質(zhì)F （左氧氟沙星相關(guān)化合物B）
|
100986-89-8
|
|
Sorafenib EP Impurity A
|
索拉非尼EP雜質(zhì)A
|
284462-37-9
|
|
Sorafenib Impurity 2
|
索拉非尼雜質(zhì)2
|
220000-87-3
|
|
Sorafenib N-Oxide
|
索拉非尼 N-氧化物
|
583840-03-3
|
|
Sorafenib Impurity 3
|
索拉非尼雜質(zhì)3
|
1129683-83-5
|
|
Sorafenib-beta-D-Glucuronide
|
索拉非尼-β-D-葡萄糖苷酸
|
1130164-93-0
|
|
Sorafenib Hemi-Tosylate
|
索拉非尼半甲苯磺酸鹽
|
2056030-06-7
|
|
Sorafenib Tosylate
|
甲苯磺酸索拉非尼
|
475207-59-1
|
|
Sorafenib Impurity 7
|
索拉非尼雜質(zhì)7
|
3505-87-1
|
|
Sorafenib Impurity 9
|
索拉非尼雜質(zhì)9
|
862875-16-9
|
|
Sorafenib Related Compound 25
|
索拉非尼相關(guān)化合物25
|
1261456-08-9
|
|
Sorafenib Impurity 11
|
索拉非尼雜質(zhì)11
|
1290546-48-3
|
|
Diquafosol Tetrasodium Salt
|
地夸磷索四鈉鹽
|
211427-08-6
|
|
Diquafosol Impurity 2
|
地夸磷索雜質(zhì)2
|
63785-59-1
|
|
Diquafosol Impurity 1
|
地夸磷索雜質(zhì)1
|
26184-65-6
|
|
Diquafosol Impurity 3
|
地夸磷索雜質(zhì)3
|
211448-70-3
|
|
Diquafosol Impurity 6
|
地夸磷索雜質(zhì)6
|
1402828-42-5
|
|
Levofloxacin-Acyl-D-Glucuronide
|
左氧氟沙星-?；?D-葡糖苷酸
|
160962-46-9
|
|
Levofloxacin Impurity 14
|
左氧氟沙星雜質(zhì)14
|
110548-02-2
|
|
Levofloxacin Impurity 15
|
左氧氟沙星雜質(zhì)15
|
103995-33-1
|
|
Levofloxacin Impurity 5
|
左氧氟沙星雜質(zhì)5
|
2206360-62-3
|
|
Levofloxacin Impurity 7
|
左氧氟沙星雜質(zhì)7
|
1607796-83-7
|
|
Levofloxacin Impurity 8
|
左氧氟沙星雜質(zhì)8
|
110548-07-7
|
|
Ofloxacin EP Impurity D (S-Isomer) HCl
|
氧氟沙星EP雜質(zhì)D（S-異構(gòu)體）鹽酸鹽
|
178912-62-4
|
|
Levofloxacin
|
左氧氟沙星
|
100986-85-4
|
|
Levofloxacin Impurity 10
|
左氧氟沙星雜質(zhì)10
|
314-62-9
|
|
Levofloxacin EP Impurity C HCl
|
左氧氟沙星EP雜質(zhì)C鹽酸鹽
|
117678-38-3
|